Feb 07, 2024 / 08:00AM GMT
Presentation
Feb 07, 2024 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Antoinette L. Gawin
Terumo Corporation - Group Managing Executive Officer and President of Blood & Cell Technologies Company
* Naoki Muto
Terumo Corporation - Chief Accounting & Financial Officer and Group Executive Officer
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Mizuho Securities Co., Ltd., Research Division - Senior Analyst
* Ryotaro Hayashi
Morgan Stanley, Research Division - Equity Analyst
* Shinnosuke Tokumoto
SMBC Nikko Securities Inc., Research Division - Analyst
* Stephen Barker
Jefferies LLC, Research Division - Equity Analyst
* Takahiro Mori
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Takashi Akahane
Tokai Tokyo Research Institute Co., Ltd. - Senior Analyst
* Tomoko
Terumo Corp
(MEX:4543)
MXN
274.75
0 (0%)
Market Cap: 534.21 Bil
Enterprise Value: 534.31 Bil
PE Ratio: 33.89
PB Ratio: 3.00
GF Score: 99/100 Q3 2024 Terumo Corp Earnings Presentation Transcript
Feb 07, 2024 / 08:00AM GMT
Release Date Price:
MXN258.86
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot